Get started
Author

Hassana el Haddaoui

Observed names: H. El Haddaoui, H. el Haddaoui, Hassana El Haddaoui
Institution: Erasmus MC
ORCID: 0000-0002-1789-6750
Observed ORCID: 0000-0002-1789-6750
OpenAlex ID: A5006707635
Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program
2022 · Hassana el Haddaoui, Rianne Brood, et al. · Cancers · 13
PDF
Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al. · Clinical Cancer Research · 12
Rintatolimod: a potential treatment in patients with pancreatic cancer expressing Toll-like receptor 3.
2023 · Hassana El Haddaoui, Casper Wf van Eijck, et al. · PubMed · 8
PDF
Adiposity is a confounding factor which largely explains the association of serum vitamin D concentrations with C-reactive protein, leptin and adiponectin
2020 · Rachida Rafiq, Hassana El Haddaoui, et al. · Cytokine · 8
1518P Stereotactic radiotherapy and IMM-101 in patients with oligometastatic pancreatic cancer following FOLFIRINOX: The MEPANC trial
2024 · L. Wismans, S. Kucukcelebi, et al. · Annals of Oncology
Data from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Data from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Figure S1 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Supplementary Table S1 - S10 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Figure S3 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Supplementary Table S1 - S10 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Figure S2 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
PDF
Figure S1 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Figure S2 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Figure S3 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
2024 · Casper W.F. van Eijck, Hassana el Haddaoui, et al.
Treating Pancreatic Ductal Adenocarcinoma Patients with Rintatolimod: Hitting Two Targets with One Arrow?
2022 · H. El Haddaoui, C.W.F. van Eijck, et al. · HPB
PDF
Works count: 16
Citation count: 41
H-index: 4
I10-index: 2
Year
Topic
Type